Recent News

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.

The findings could pave the way toward more targeted treatments for the disease.

At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.

The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.

The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.

A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.

Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.